Market Overview:
The global isoflurane market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for isoflurane in hospitals and other medical institutions. Isoflurane is used as an anaesthetic agent in humans and animals, which has led to its widespread adoption across the globe. Additionally, the growing awareness about the benefits of using isoflurane over traditional anaesthetics are also contributing towards the growth of this market.
Product Definition:
Isoflurane is a general anesthetic agent that can be used for induction and maintenance of anesthesia. It has a rapid onset and short duration of action, making it ideal for use in outpatient surgery. Isoflurane also has a relatively low blood/gas partition coefficient, which minimizes the potential for cardiac depression.
Human Series:
Human series is a group of medicines that are used to treat diseases and disorders caused by viruses, bacteria, and other microorganisms. The main goal of this series is to provide the body with the immune system support in order to fight against infections. It also helps in increasing resistance towards bacterial infection & lowering chances of getting infected during surgeries along with providing general well-being.
The global human series market size was valued at USD 7 billion in 2015.
Animal Series:
Animal series is a method of producing an isoflurane anesthetic gas by heating animal fats or oils. Isoflurane, produced in this way, has the same molecular structure as that of natural human breathable air. It's easier to handle and transport than other gases such as nitrogen and carbon dioxide which makes it more preferable for use in anesthesia procedures.
Application Insights:
The global isoflurane market has witnessed significant growth in the past few years owing to its wide application scope in various medical procedures. The major applications of isoflurane include hospitals and other medical institutions. Hospitals accounted for a revenue share of over 70% in 2017 and are expected to witness significant growth over the forecast period due to rising demand for anesthesia services across the globe. Other applications include anesthetic agents used during surgeries, dental care, OPD sessions, dentistry, veterinary clinics & animal hospitals among others. These agents have a wider application scope as they are non-toxic and less expensive than other anesthetics such as halogenated hydrocarbon or nitrous oxide which are widely used across these sectors globally owing to their higher costliness compared with isoflurane (lesser cost).
Regional Analysis:
North America dominated the global isoflurane market in 2017. The growth can be attributed to rising demand for medical gases in hospitals and other medical institutions, coupled with favorable reimbursement policies. In North America, the U.S., Canada and Mexico are major markets for isoflurane due to its high availability at low prices along with easy access to healthcare services for all citizens of these countries.
The Asia Pacific region is expected to witness significant growth over the forecast period owing to increasing awareness about various treatment options available along with growing disposable income of people in this region which will ultimately drive demand for medical gases such as isoflurane over the forecast period from 2018-2030 (see Figure 1). Moreover, rapidly developing economies such as India and China are anticipated to fuel regional product demand during the forecast period (see Table 1).
Growth Factors:
- Increasing demand for general anesthesia in surgeries
- Rising geriatric population susceptible to various diseases
- Growing number of outpatient procedures requiring anesthesia
- Technological advancements in inhalation anesthetics market
- Emergence of new surgical procedures
Scope Of The Report
Report Attributes
Report Details
Report Title
Isoflurane Market Research Report
By Type
Human Series, Animal Series
By Application
Hospitals, Other Medical Institutions
By Companies
Piramal Critical Care(Piramal Group), Halocarbon, Aesica(Consort Medical Group), Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd., Pfizer, Indofine Chemical Company, Inc., Medicon Lifesciences, Rewine Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Isoflurane Market Report Segments:
The global Isoflurane market is segmented on the basis of:
Types
Human Series, Animal Series
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Other Medical Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Piramal Critical Care(Piramal Group)
- Halocarbon
- Aesica(Consort Medical Group)
- Lunan Pharmaceutical Group
- Shandong Keyuan Pharmaceutical Co., Ltd.
- Pfizer
- Indofine Chemical Company, Inc.
- Medicon Lifesciences
- Rewine Pharmaceutical
Highlights of The Isoflurane Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Series
- Animal Series
- By Application:
- Hospitals
- Other Medical Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Isoflurane Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Isoflurane is a gas used in anesthesiology. It is a short-acting anesthetic that works by blocking nerve impulses.
Some of the major companies in the isoflurane market are Piramal Critical Care(Piramal Group), Halocarbon, Aesica(Consort Medical Group), Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd., Pfizer, Indofine Chemical Company, Inc., Medicon Lifesciences, Rewine Pharmaceutical.
The isoflurane market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Isoflurane Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Isoflurane Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Isoflurane Market - Supply Chain
4.5. Global Isoflurane Market Forecast
4.5.1. Isoflurane Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Isoflurane Market Size (000 Units) and Y-o-Y Growth
4.5.3. Isoflurane Market Absolute $ Opportunity
5. Global Isoflurane Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Isoflurane Market Size and Volume Forecast by Type
5.3.1. Human Series
5.3.2. Animal Series
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Isoflurane Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Isoflurane Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Other Medical Institutions
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Isoflurane Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Isoflurane Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Isoflurane Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Isoflurane Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Isoflurane Demand Share Forecast, 2019-2026
9. North America Isoflurane Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Isoflurane Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Isoflurane Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Other Medical Institutions
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Isoflurane Market Size and Volume Forecast by Type
9.7.1. Human Series
9.7.2. Animal Series
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Isoflurane Demand Share Forecast, 2019-2026
10. Latin America Isoflurane Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Isoflurane Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Isoflurane Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Other Medical Institutions
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Isoflurane Market Size and Volume Forecast by Type
10.7.1. Human Series
10.7.2. Animal Series
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Isoflurane Demand Share Forecast, 2019-2026
11. Europe Isoflurane Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Isoflurane Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Isoflurane Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Other Medical Institutions
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Isoflurane Market Size and Volume Forecast by Type
11.7.1. Human Series
11.7.2. Animal Series
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. BySales Channel
11.11. Europe Isoflurane Demand Share, 2019-2026
12. Asia Pacific Isoflurane Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Isoflurane Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Isoflurane Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Other Medical Institutions
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Isoflurane Market Size and Volume Forecast by Type
12.7.1. Human Series
12.7.2. Animal Series
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Isoflurane Demand Share, 2019-2026
13. Middle East & Africa Isoflurane Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Isoflurane Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Isoflurane Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Other Medical Institutions
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Isoflurane Market Size and Volume Forecast by Type
13.7.1. Human Series
13.7.2. Animal Series
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Isoflurane Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Isoflurane Market: Market Share Analysis
14.2. Isoflurane Distributors and Customers
14.3. Isoflurane Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Piramal Critical Care(Piramal Group)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Halocarbon
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aesica(Consort Medical Group)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lunan Pharmaceutical Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Shandong Keyuan Pharmaceutical Co., Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Indofine Chemical Company, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medicon Lifesciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Rewine Pharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
